Guideline values and human risk assessment for the presence of anti-inflammatory drugs remaining in drinking water after lab scale treatment. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 54, n. 1, p. e17320, 2018. DOI: 10.1590/s2175-97902018000117320. Disponível em: https://www.revistas.usp.br/bjps/article/view/146840.. Acesso em: 5 may. 2024.